The mechanisms by which sphingosine and these sphingosine-like compounds limit tumor growth are not well defined but likely involve PP2A activation (Patmanathan et al, 2015; Hannun and Obeid, 2018; Kim et al, 2016). The gene discussed is PTPA; the disease is neoplasm.